{"id":3214,"date":"2013-10-11T09:50:00","date_gmt":"2013-10-11T09:50:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivo-perfusion-stammer-vivoline\/"},"modified":"2013-10-11T09:50:00","modified_gmt":"2013-10-11T09:50:00","slug":"xvivo-perfusion-stammer-vivoline","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/","title":{"rendered":"XVIVO Perfusion st\u00e4mmer Vivoline"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>XVIVO Perfusion st\u00e4mmer Vivoline f\u00f6r att s\u00e4kerst\u00e4lla sina exklusiva r\u00e4ttigheter till Vivolines patent avseende tre produkter uppfunna av Professor Stig Steen.<\/strong><\/div>\n<\/p>\n<p><span>XVIVO Perfusion AB (publ) har idag inlett r\u00e4ttsligt f\u00f6rfarande mot Vivoline Medical AB (publ) f\u00f6r att s\u00e4kerst\u00e4lla de exklusiva globala obegr\u00e4nsade r\u00e4ttigheter som XVIVO Perfusion har till vissa av Professor Stig Steen utvecklade medier f\u00f6r evaluering och preservation av organ i samband med transplantation. <\/span><\/p>\n<p><span>XVIVO Perfusions egna produkt STEEN Solution\u2122, som \u00e4r under lansering i Europa, omfattas inte av tvisten och skyddas av beviljat patent som l\u00f6per till \u00e5r 2021. <\/span><\/p>\n<p><span>Enligt g\u00e4llande avtal med Professor Stig Steen och Igel\u00f6sa Life Science AB (som \u00e4r st\u00f6rsta \u00e4gare till Vivoline Medical) har XVIVO Perfusion globala obegr\u00e4nsade icke upps\u00e4gningsbara exklusiva r\u00e4ttigheter till medier och relaterade patent f\u00f6r preservation och evaluering av organ som bygger p\u00e5 LPD (low potassium dextran), med tillsatser av kalcium, skapade av Professor Stig Steen. <\/span><\/p>\n<p><span>Ett antal av Vivoline Medicals produkter och relaterade patentr\u00e4ttigheter avser, av Professor Stig Steen skapade medier, f\u00f6r preservation och evaluering av organ som bygger p\u00e5 LPD med tillsats av kalcium. Ett s\u00e5dant patent som allts\u00e5 omfattas av XVIVO Perfusions exklusiva r\u00e4ttigheter \u00e4r patentet som skyddar Vivoline Medicals planerade produkt SS2, en l\u00f6sning f\u00f6r att rekonditionera och evaluera lungor inf\u00f6r transplantation. \u00c4ven Vivoline Medicals produkter Heartadex 1 och 2 skyddas av patent och patentans\u00f6kningar som omfattas av XVIVO Perfusions r\u00e4ttigheter enligt den information som g\u00e5r att utl\u00e4sa i Vivoline Medicals memorandum fr\u00e5n april 2013.<\/span><\/p>\n<p><span>Magnus Nilsson, XVIVO Perfusions VD uppger: \u201dXVIVO Perfusion ser allvarligt p\u00e5 och kommer att ingripa mot\u00a0kr\u00e4nkningar av bolagets immateriella r\u00e4ttigheter. Vi avser att forts\u00e4tta utveckla och kommersialisera Professor Stig Steens medier p\u00e5 b\u00e4sta s\u00e4tt f\u00f6r att skapa v\u00e4rde f\u00f6r patienter, kunder och aktie\u00e4gare. Att inleda ett r\u00e4ttsligt f\u00f6rfarande f\u00f6r att s\u00e4kerst\u00e4lla XVIVO Perfusions exklusiva r\u00e4ttigheter till Vivoline Medicals medier som har utvecklats av Professor Stig Steen \u00e4r ett led i denna strategi.\u201d<\/span><\/p>\n<\/p>\n<p><span>G\u00f6teborg 11 oktober 2013<br \/><\/span><span>XVIVO Perfusion AB (publ)<\/span><\/p>\n<\/p>\n<div class=\"mfn-footer\">\n<p><span>F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, tel: 031-788 21 59, e-post: <a href=\"mailto:christoffer.rosenblad@xvivperfusion.com\" rel=\"nofollow\">christoffer.rosenblad@xvivoperfusion.com<\/a><br \/><\/span><span><br \/>Xvivo Perfusion\u00a0\u00e4r skyldigt att offentligg\u00f6ra informationen i detta pressmeddelande enligt lagen om v\u00e4rdepappersmarknaden och\/eller lagen om handel med finansiella instrument. Informationen l\u00e4mnades f\u00f6r publicering den\u00a011\u00a0oktober 2013 kl. 11:50.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>XVIVO Perfusion st\u00e4mmer Vivoline f\u00f6r att s\u00e4kerst\u00e4lla sina exklusiva r\u00e4ttigheter till Vivolines patent avseende tre produkter uppfunna av Professor Stig&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-3214","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-vpml","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>XVIVO Perfusion st\u00e4mmer Vivoline - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVO Perfusion st\u00e4mmer Vivoline - XVIVO\" \/>\n<meta property=\"og:description\" content=\"XVIVO Perfusion st\u00e4mmer Vivoline f\u00f6r att s\u00e4kerst\u00e4lla sina exklusiva r\u00e4ttigheter till Vivolines patent avseende tre produkter uppfunna av Professor Stig...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-stammer-vivoline\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-stammer-vivoline\\\/\",\"name\":\"XVIVO Perfusion st\u00e4mmer Vivoline - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2013-10-11T09:50:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-stammer-vivoline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-stammer-vivoline\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-stammer-vivoline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVO Perfusion st\u00e4mmer Vivoline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVO Perfusion st\u00e4mmer Vivoline - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/","og_locale":"en_US","og_type":"article","og_title":"XVIVO Perfusion st\u00e4mmer Vivoline - XVIVO","og_description":"XVIVO Perfusion st\u00e4mmer Vivoline f\u00f6r att s\u00e4kerst\u00e4lla sina exklusiva r\u00e4ttigheter till Vivolines patent avseende tre produkter uppfunna av Professor Stig...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/","name":"XVIVO Perfusion st\u00e4mmer Vivoline - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2013-10-11T09:50:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-stammer-vivoline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVO Perfusion st\u00e4mmer Vivoline"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}